LEADER 01887nas  2200589-a 450 
001 996198235103316
005 20231213213019.0
011   $a1538-8514
035   $a(DE-599)ZDB2062135-8
035   $a(OCoLC)48984060
035   $a(CKB)111022849554084
035   $a(CONSER)--2002213731
035   $a(EXLCZ)99111022849554084
100   $a20020212a20019999  s--         a
101 0 $aeng
135   $aurc|u||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aMolecular cancer therapeutics
210   $a[Philadelphia, Pa.] $cAmerican Association for Cancer Research$dİ2001-
300   $aRefereed/Peer-reviewed
300   $aTitle from title screen (viewed Feb. 11, 2002).
300   $aHighWire Press assists in the publication of this journal.
311   $a1535-7163 
531   $aMOL CANCER THER
531   $aMOL. CANCER THER
531 0 $aMol. cancer ther.
606   $aCancer$xMolecular aspects$vPeriodicals
606   $aCancer$xTreatment$vPeriodicals
606   $aMolecular Biology$vPeriodicals
606   $aNeoplasms$xtherapy$vPeriodicals
606   $aMolecular Biology
606   $aNeoplasms$xtherapy
606   $aCancer$xMolecular aspects$2fast$3(OCoLC)fst00845397
606   $aCancer$xTreatment$2fast$3(OCoLC)fst00845538
608   $aPeriodicals.$2fast
615  0$aCancer$xMolecular aspects
615  0$aCancer$xTreatment
615  2$aMolecular Biology
615  2$aNeoplasms$xtherapy
615  2$aMolecular Biology.
615  2$aNeoplasms$xtherapy.
615  7$aCancer$xMolecular aspects.
615  7$aCancer$xTreatment.
676   $a615
712 02$aAmerican Association for Cancer Research.
712 02$aHighWire Press.
906   $aJOURNAL
912   $a996198235103316
996   $aMolecular cancer therapeutics$91031422
997   $aUNISA